Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-06-16 Exercise | 2025-06-17 5:53 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 12,500 | $0 | 173,649 (Direct) | View |
2025-06-06 Exercise | 2025-06-09 7:54 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 12,500 | $0 | 160,066 (Direct) | View |
2025-05-06 Option Award | 2025-05-07 12:20 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Hensley Mark Earl Chief Operating Officer | 500,000 | $0 | 500,000 (Direct) | View |
2025-04-30 Exercise | 2025-05-02 8:41 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 11,694 | $0 | 297,982 (Direct) | View |
2025-04-30 Exercise | 2025-05-02 8:32 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 11,694 | $0 | 311,565 (Direct) | View |
2025-04-30 Exercise | 2025-05-02 8:23 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 34,789 | $0 | 947,783 (Direct) | View |
2025-04-19 Exercise | 2025-04-22 10:08 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,875 | $0 | 153,489 (Direct) | View |
2025-04-19 Exercise | 2025-04-22 09:57 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 3,875 | $0 | 167,072 (Direct) | View |
2025-04-19 Exercise | 2025-04-22 09:39 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 13,796 | $0 | 542,929 (Direct) | View |
2025-04-03 Exercise | 2025-04-03 5:48 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 62,500 | $0 | 502,367 (Direct) | View |
2025-01-31 Option Award(A) | 2025-02-04 5:40 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director | 53,850 | $0 | 91,729 (Direct) | View |
2025-01-31 Option Award(A) | 2025-02-04 5:37 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 53,850 | $0 | 7,092,421 (Direct) | View |
2025-01-31 Option Award(A) | 2025-02-04 5:34 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director | 53,850 | $0 | 123,080 (Direct) | View |
2025-01-31 Option Award(A) | 2025-02-04 5:30 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director | 53,850 | $0 | 119,670 (Direct) | View |
2025-01-31 Option Award(A) | 2025-02-04 5:27 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director | 53,850 | $0 | 123,080 (Direct) | View |
2025-01-31 Option Award(A) | 2025-02-04 5:23 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Christian Waage Director | 53,850 | $0 | 120,030 (Direct) | View |
2025-01-31 Option Award | 2025-02-04 12:44 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 561,330 | $0 | 561,330 (Direct) | View |
2025-01-31 Option Award | 2025-02-04 12:44 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 561,330 | $0 | 561,330 (Direct) | View |
2025-01-31 Option Award | 2025-02-04 12:43 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 1,669,860 | $0 | 1,669,860 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:58 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director | 17,950 | $0 | 91,729 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:58 am | N/A 2035-01-30 | HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director | 35,900 | $1.73 | 91,729 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:48 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director | 17,950 | $0 | 123,080 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:48 am | N/A 2035-01-30 | HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director | 35,900 | $1.73 | 123,080 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:41 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director | 17,950 | $0 | 119,670 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:41 am | N/A 2035-01-30 | HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director | 35,900 | $1.73 | 119,670 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:33 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director | 17,950 | $0 | 123,080 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:33 am | N/A 2035-01-30 | HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director | 35,900 | $1.73 | 123,080 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:32 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Christian Waage Director | 17,950 | $0 | 120,030 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 11:32 am | N/A 2035-01-30 | HERON THERAPEUTICS INC. | HRTX | Christian Waage Director | 35,900 | $1.73 | 120,030 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 09:17 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 17,950 | $0 | 7,092,421 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 09:17 am | N/A 2035-01-30 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 35,900 | $1.73 | 7,092,421 (Direct) | View |
2025-01-19 Exercise | 2025-01-22 09:32 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 3,874 | $0 | 167,072 (Direct) | View |
2025-01-19 Exercise | 2025-01-22 09:15 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,874 | $0 | 153,489 (Direct) | View |
2025-01-19 Exercise | 2025-01-22 09:06 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 13,797 | $0 | 480,429 (Direct) | View |
2024-11-04 Option Award | 2024-11-06 2:08 pm | N/A 2034-11-04 | HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director | 227,272 | $1.78 | 265,151 (Direct) | View |
2024-11-04 Option Award | 2024-11-06 2:08 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director | 37,879 | $0 | 265,151 (Direct) | View |
2024-10-19 Exercise | 2024-10-21 3:55 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 3,874 | $0 | 158,367 (Direct) | View |
2024-10-19 Exercise | 2024-10-21 3:53 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,874 | $0 | 153,489 (Direct) | View |
2024-10-19 Exercise | 2024-10-21 3:49 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 13,797 | $0 | 469,746 (Direct) | View |
2024-07-19 Exercise | 2024-07-22 09:54 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 13,797 | $0 | 469,746 (Direct) | View |
2024-07-19 Exercise | 2024-07-22 09:44 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,875 | $0 | 153,489 (Direct) | View |
2024-07-19 Exercise | 2024-07-22 09:32 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 3,875 | $0 | 158,367 (Direct) | View |
2024-06-16 Exercise | 2024-06-17 2:21 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 12,500 | $0 | 137,752 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 09:34 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 12,500 | $0 | 132,874 (Direct) | View |